These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30616790)

  • 1. From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach.
    Karsten RT; Stuiver MM; van der Molen L; Navran A; de Boer JP; Hilgers FJM; Klop WMC; Smeele LE
    Oral Oncol; 2019 Jan; 88():172-179. PubMed ID: 30616790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.
    Willemsen ACH; Kok A; van Kuijk SMJ; Baijens LWJ; de Bree R; Devriese LA; Hoebers FJP; Lalisang RI; Schols AMWJ; Terhaard CHJ; Hoeben A
    Clin Nutr; 2020 Aug; 39(8):2600-2608. PubMed ID: 31839429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.
    Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
    J Acad Nutr Diet; 2018 Apr; 118(4):627-636. PubMed ID: 27986517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrostomy vs nasogastric tube feeding in patients with head and neck cancer during radiotherapy alone or combined chemoradiotherapy.
    Soria A; Santacruz E; Vega-Piñeiro B; Gión M; Molina J; Villamayor M; Mateo R; Riveiro J; Nattero L; Botella-Carretero JI
    Nutr Hosp; 2017 Jun; 34(3):512-516. PubMed ID: 28627183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
    Willemsen ACH; Kok A; Baijens LWJ; de Boer JP; de Bree R; Devriese LA; Driessen CML; van Herpen CML; Hoebers FJP; Kaanders JHAM; Karsten RT; van Kuijk SMJ; Lalisang RI; Navran A; Pereboom SR; Schols AMWJ; Terhaard CHJ; Hoeben A
    Clin Nutr; 2022 Jan; 41(1):177-185. PubMed ID: 34883306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study.
    Wiggenraad RG; Flierman L; Goossens A; Brand R; Verschuur HP; Croll GA; Moser LE; Vriesendorp R
    Clin Otolaryngol; 2007 Oct; 32(5):384-90. PubMed ID: 17883560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Prophylactic Gastrostomy Tube Placement and Gastrostomy Tube Usage in Patients Treated by Radio(chemo)therapy for Head and Neck Cancer.
    Sieron HL; Eberle F; Gress TM; Mahnken AH; Wiegand S
    Anticancer Res; 2020 Feb; 40(2):1167-1173. PubMed ID: 32014970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT.
    Paleri V; Patterson J; Rousseau N; Moloney E; Craig D; Tzelis D; Wilkinson N; Franks J; Hynes AM; Heaven B; Hamilton D; Guerrero-Urbano T; Donnelly R; Barclay S; Rapley T; Stocken D
    Health Technol Assess; 2018 Apr; 22(16):1-144. PubMed ID: 29650060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors for reactive tube feeding in patients with advanced oropharynx cancer receiving radiotherapy ± chemotherapy.
    Vangelov B; Smee RI
    Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3741-3749. PubMed ID: 28748260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?
    Mekhail TM; Adelstein DJ; Rybicki LA; Larto MA; Saxton JP; Lavertu P
    Cancer; 2001 May; 91(9):1785-90. PubMed ID: 11335904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus-negative head and neck cancer.
    Ward MC; Bhateja P; Nwizu T; Kmiecik J; Reddy CA; Scharpf J; Lamarre ED; Burkey BB; Greskovich JF; Adelstein DJ; Koyfman SA
    Head Neck; 2016 Apr; 38 Suppl 1():E1054-60. PubMed ID: 26045168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study comparing prophylactic gastrostomy to nutritional counselling with a therapeutic feeding tube if required in head and neck cancer patients undergoing chemoradiotherapy in Thai real-world practice.
    Pramyothin P; Manyanont S; Trakarnsanga A; Petsuksiri J; Ithimakin S
    J Hum Nutr Diet; 2016 Dec; 29(6):768-776. PubMed ID: 27028666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment factors associated with functional oral intake and feeding tube use at 1 and 6 months post-radiotherapy (+/- chemotherapy) for head and neck cancer.
    Barnhart MK; Ward EC; Cartmill B; Robinson RA; Simms VA; Chandler SJ; Wurth ET; Smee RI
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):507-516. PubMed ID: 27498203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review.
    Koyfman SA; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):581-9. PubMed ID: 22857885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prophylactic percutaneous endoscopic gastrostomy with reactive enteral nutrition in patients with head and neck cancer undergoing radiotherapy or chemoradiotherapy: A systematic review.
    Mellors K; Ye X; Van Den Brande J; Wai Ray Mak T; Brown T; Findlay M; Bauer J
    Clin Nutr ESPEN; 2021 Dec; 46():87-98. PubMed ID: 34857252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer.
    Karsten RT; Al-Mamgani A; Bril SI; Tjon-A-Joe S; van der Molen L; de Boer JP; Hilgers FJM; Smeele LE; van den Brekel MWM; Stuiver MM
    Head Neck; 2019 Nov; 41(11):4000-4008. PubMed ID: 31472000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic versus reactive gastrostomy tube placement in advanced head and neck cancer treated with definitive chemoradiotherapy: A systematic review.
    McClelland S; Andrews JZ; Chaudhry H; Teckie S; Goenka A
    Oral Oncol; 2018 Dec; 87():77-81. PubMed ID: 30527247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary survey on use of feeding tubes in head and neck cancer patients undergoing chemoradiotherapy in Germany-the SUFEETUBE project.
    Löser A; Fabian A; Rühle A; Thieme A; Baehr A; Käsmann L; Zwaan I; Kahle B; Soror T; Kunte A; Seyedi N; Kebenko M; Seidel C; Dierks F; Krause L; Bruchhage KL; Rades D
    Strahlenther Onkol; 2024 Jul; 200(7):583-594. PubMed ID: 38381142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feeding tube use in patients with head and neck cancer.
    Lewis SL; Brody R; Touger-Decker R; Parrott JS; Epstein J
    Head Neck; 2014 Dec; 36(12):1789-95. PubMed ID: 24478227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.